Top compounds associated with response to C18orf63


Feature Type Standardized
Nominal ANOVA
mRNA pandacostat CTRPv2 pan-cancer AAC -0.016 0.7
mRNA Bortezomib gCSI pan-cancer AAC 0.025 0.7
mRNA thalidomide CTRPv2 pan-cancer AAC -0.022 0.7
mRNA MK 1775 CTRPv2 pan-cancer AAC 0.014 0.7
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.014 0.7
mRNA BRD-K03911514 CTRPv2 pan-cancer AAC 0.022 0.7
mRNA fulvestrant CTRPv2 pan-cancer AAC -0.033 0.7
mRNA OSI-930 CTRPv2 pan-cancer AAC -0.015 0.7
mRNA SN-38 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
Download CSV